Akshay Vaishnaw, EVP, Chief Medical Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 10,625 shares at $71.34 ($766K) on 2014-09-16, disclosed to the SEC on 2014-09-17.
Scheduled sale ($766k) by EVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.34 | 3,200 | $228K | 29.8% |
| 2 | $72.27 | 6,625 | $479K | 62.5% |
| 3 | $73.03 | 800 | $58K | 7.6% |
| Total | $72.05 avg | 10,625 | $766K | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |